Profitability
Weight: 25%
F
17
- 5yr Avg ROIC 2.9%
- Operating Margin Trend -3.45 pp/yr
SUPN
Supernus Pharmaceuticals, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
D
33
- 5yr Avg ROE 3.4%
- 5yr Share-Count CAGR 1.0%
Growth Quality
Weight: 25%
B
72
- 5yr Revenue CAGR 6.7%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 20%
B+
77
- 5yr FCF Margin 17.9%
- 5yr FCF/NI Conversion 22.64x
Balance Sheet
Weight: 10%
A+
100
- Net Debt / EBITDA -6.29x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 5.22
Stability
Weight: 5%
D+
43
- EPS Volatility (σ/μ) 0.60
- Negative-Revenue Years (5) 1/5
- Piotroski F-Score 4
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 1 new buy; 1 added; 1 full exit.
- Holders
- 2
- Avg Δ position
- +23.3%
- New buys
- 1
- Full exits
- 1
- Greenblatt new
- Wood sold -100%
- Cooperman increased +23%